查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945290

2026年全球止血劑和組織密封膠市場報告

Hemostats And Tissue Sealants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，止血劑和組織黏合劑市場經歷了顯著成長，預計將從2025年的43.5億美元成長到2026年的46.4億美元，複合年成長率為6.7%。成長要素包括對傳統機械止血裝置的依賴、合成密封劑供應有限、手術量增加、醫院基礎設施擴建以及纖維蛋白基密封劑的早期應用。

預計未來幾年，止血劑和組織黏合劑市場規模將強勁成長，到2030年將達到59.7億美元，複合年成長率（CAGR）為6.5%。預測期內的成長可歸因於新一代組織黏合劑的研發、微創手術的興起、心血管和創傷手術的拓展、止血技術研究的增加以及直銷和線上分銷管道的擴張。預測期內的主要趨勢包括：先進止血產品的日益普及、合成和複合密封劑使用量的增加、心血管和創傷手術的拓展、對微創和快速康復手術的關注，以及止血領域研發和學術應用的不斷增加。

預計外科手術數量的增加將推動止血劑和組織密封膠市場的擴張。外科手術是指外科醫師使用各種技術和器械對病變組織或器官進行診斷、治療或切除，或恢復身體功能的手術。手術數量的增加主要是由於慢性病盛行率的上升。慢性病通常需要手術介入才能妥善管理和治療，並預防併發症。止血劑和組織密封膠在有效控制出血和密封組織、最大限度地減少併發症和改善手術效果方面發揮關鍵作用。例如，2024年6月，總部位於美國的國際美容整形外科學會（ISAPS，一個由獲得認證的美容整形外科醫生組成的專業協會）報告稱，2023年全球外科手術數量成長了5.5%，超過1580萬例，非手術治療數量超過1910萬例。這一趨勢凸顯了外科手術數量的增加如何推動了對止血劑和組織密封膠的需求。

止血和組織密封膠市場的主要企業正優先開發創新產品，例如即用型可吸收膠原蛋白貼片，以提高外科手術的有效性和效率。這些基於膠原蛋白的止血劑採用生物活性可吸收材料製成，無需任何準備，即可即時使用，有效密封組織並止血。 2025年4月，總部位於美國的醫療公司百特國際在奧地利舉辦的研討會上推出了「Hemopatch 密封止血貼」。這款新產品無需開放性手術即可使用，無需冷藏或額外準備。 Hemopatch 具有強大的黏合性、較長的保存期限和快速止血效果，可簡化術中出血和滲漏的處理，從而提高手術精度，並加快患者在各種專科領域的康復。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球止血劑及組織密封膠市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 工業4.0和智慧製造
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 自主系統、機器人與智慧運輸
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 先進止血產品的應用日益廣泛
    • 合成和複合密封劑的使用日益增多
    • 擴大心血管和創傷外科手術
    • 專注於微創手術，以加快恢復速度。
    • 拓展止血領域的研究與學術應用範圍

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心（ASC）
  • 專科診所
  • 研究和學術機構
  • 心血管與創傷中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球止血劑和組織密封膠市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球止血劑及組織密封膠市場規模、比較及成長率分析
  • 全球止血劑和組織密封膠市場表現：規模和成長，2020-2025年
  • 全球止血劑和組織密封膠市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 局部止血劑、黏合劑和組織密封膠、纖維蛋白膠、其他產品類型
  • 按成分
  • 生物來源的、合成的和複雜的
  • 透過分銷管道
  • 直銷、經銷商、線上銷售
  • 透過使用
  • 外科手術、創傷、心血管、一般外科及其他應用
  • 最終用戶
  • 醫院、門診手術中心、專科診所、研究及學術機構
  • 按類型細分：局部止血劑
  • 機械止血劑、活性止血劑、流動性止血劑及混合型止血劑
  • 按類型細分：黏合劑和組織密封膠
  • 合成組織黏合劑、生物組織黏合劑、氰基丙烯酸黏合劑
  • 按類型細分：纖維蛋白膠
  • 液態纖維蛋白膠，貼片式纖維蛋白膠
  • 按類型細分：其他產品類型
  • 明膠基止血劑、膠原蛋白基止血劑、氧化再生纖維素基止血劑

第10章 區域與國家分析

  • 全球止血劑及組織密封膠市場：區域分析、預測及展望（2020-2025年、2025-2030年、2035年）。
  • 全球止血劑和組織密封膠市場：按國家/地區、績效和預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 止血劑和組織密封膠市場：競爭格局和市場佔有率，2024 年
  • 止血劑與組織密封膠市場：公司估值矩陣
  • 止血劑和組織密封膠市場：公司概況
    • Johnson & Johnson
    • Medtronic plc
    • Becton, Dickinson and Company（BD）
    • Stryker Corporation
    • Baxter International Inc.

第37章：其他領先和創新企業

  • Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年止血劑和組織密封膠市場：提供新機會的國家
  • 2030年止血劑與組織密封膠市場：充滿新機會的細分市場
  • 2030年止血劑和組織密封膠市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MHTSI01_G26Q1

Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.

The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.

Tariffs are impacting the hemostats and tissue sealants market by increasing costs of imported biological and synthetic raw materials used in product manufacturing. Segments such as fibrin sealants and combination hemostats are most impacted, with Asia-Pacific regions like China and India facing significant import duties. This has led to higher production costs and supply chain delays. Positively, tariffs have driven local manufacturing initiatives, encouraged material innovation, and promoted investment in domestic production capabilities.

The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, detailed hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.35 billion in 2025 to $4.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to reliance on traditional mechanical hemostats, limited availability of synthetic sealants, increasing surgical procedures, growing hospital infrastructure, early adoption of fibrin-based sealants.

The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of next-generation tissue adhesives, rising minimally invasive surgeries, growing cardiovascular and trauma surgeries, increased research in hemostasis technologies, expansion of direct and online distribution channels. Major trends in the forecast period include rising adoption of advanced hemostatic products, increased use of synthetic and combination sealants, expansion of cardiovascular and trauma surgeries, focus on minimally invasive and faster recovery procedures, growing research and academic applications in hemostasis.

The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.

Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.

In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats And Tissue Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Topical Hemostats; Adhesives And Tissue Sealants; Fibrin Sealants; Other Product Types
  • 2) By Composition: Biological Based; Synthetic Based; Combination
  • 3) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 4) By Application: Surgical Procedures; Trauma Cases; Cardiovascular Surgery; General Surgery; Other Applications
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics; Research And Academic Institutes
  • Subsegments:
  • 1) By Topical Hemostats: Mechanical Hemostats; Active Hemostats; Flowable Hemostats; Combination Hemostats
  • 2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives; Biological Tissue Adhesives; Cyanoacrylate-Based Adhesives
  • 3) By Fibrin Sealants: Liquid Fibrin Sealants; Patch-Based Fibrin Sealants
  • 4) By Other Product Types: Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Becton Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; Corza Medical Inc.; Artivion Inc.; Ethicon Inc.; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Samyang Holdings Corporation; 3-D Matrix Medical Technology Co Ltd.; GELITA AG; BioCer Entwicklungs-GmbH; AEGIS Lifesciences Pvt. Ltd.; Betatech Medical Ltd.; Cohera Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hemostats And Tissue Sealants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hemostats And Tissue Sealants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hemostats And Tissue Sealants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hemostats And Tissue Sealants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Advanced Hemostatic Products
    • 4.2.2 Increased Use Of Synthetic And Combination Sealants
    • 4.2.3 Expansion Of Cardiovascular And Trauma Surgeries
    • 4.2.4 Focus On Minimally Invasive And Faster Recovery Procedures
    • 4.2.5 Growing Research And Academic Applications In Hemostasis

5. Hemostats And Tissue Sealants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers (Ascs)
  • 5.3 Specialized Clinics
  • 5.4 Research And Academic Institutes
  • 5.5 Cardiovascular And Trauma Centers

6. Hemostats And Tissue Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hemostats And Tissue Sealants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hemostats And Tissue Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hemostats And Tissue Sealants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hemostats And Tissue Sealants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hemostats And Tissue Sealants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hemostats And Tissue Sealants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hemostats And Tissue Sealants Market Segmentation

  • 9.1. Global Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types
  • 9.2. Global Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biological Based, Synthetic Based, Combination
  • 9.3. Global Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Sales, Distributors, Online Sales
  • 9.4. Global Hemostats And Tissue Sealants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications
  • 9.5. Global Hemostats And Tissue Sealants Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes
  • 9.6. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Topical Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats
  • 9.7. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Adhesives And Tissue Sealants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives
  • 9.8. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid Fibrin Sealants, Patch-Based Fibrin Sealants
  • 9.9. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

10. Hemostats And Tissue Sealants Market Regional And Country Analysis

  • 10.1. Global Hemostats And Tissue Sealants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hemostats And Tissue Sealants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hemostats And Tissue Sealants Market

  • 11.1. Asia-Pacific Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hemostats And Tissue Sealants Market

  • 12.1. China Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hemostats And Tissue Sealants Market

  • 13.1. India Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hemostats And Tissue Sealants Market

  • 14.1. Japan Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hemostats And Tissue Sealants Market

  • 15.1. Australia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hemostats And Tissue Sealants Market

  • 16.1. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hemostats And Tissue Sealants Market

  • 17.1. South Korea Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hemostats And Tissue Sealants Market

  • 18.1. Taiwan Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hemostats And Tissue Sealants Market

  • 19.1. South East Asia Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hemostats And Tissue Sealants Market

  • 20.1. Western Europe Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hemostats And Tissue Sealants Market

  • 21.1. UK Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hemostats And Tissue Sealants Market

  • 22.1. Germany Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hemostats And Tissue Sealants Market

  • 23.1. France Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hemostats And Tissue Sealants Market

  • 24.1. Italy Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hemostats And Tissue Sealants Market

  • 25.1. Spain Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hemostats And Tissue Sealants Market

  • 26.1. Eastern Europe Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hemostats And Tissue Sealants Market

  • 27.1. Russia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hemostats And Tissue Sealants Market

  • 28.1. North America Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hemostats And Tissue Sealants Market

  • 29.1. USA Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hemostats And Tissue Sealants Market

  • 30.1. Canada Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hemostats And Tissue Sealants Market

  • 31.1. South America Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hemostats And Tissue Sealants Market

  • 32.1. Brazil Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hemostats And Tissue Sealants Market

  • 33.1. Middle East Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hemostats And Tissue Sealants Market

  • 34.1. Africa Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hemostats And Tissue Sealants Market Regulatory and Investment Landscape

36. Hemostats And Tissue Sealants Market Competitive Landscape And Company Profiles

  • 36.1. Hemostats And Tissue Sealants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hemostats And Tissue Sealants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hemostats And Tissue Sealants Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Hemostats And Tissue Sealants Market Other Major And Innovative Companies

  • Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

38. Global Hemostats And Tissue Sealants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hemostats And Tissue Sealants Market

40. Hemostats And Tissue Sealants Market High Potential Countries, Segments and Strategies

  • 40.1 Hemostats And Tissue Sealants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hemostats And Tissue Sealants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hemostats And Tissue Sealants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer